Importer of Controlled Substances Application: Chattem Chemicals, Inc., 60501-60502 [2014-23827]
Download as PDF
<![CDATA[
60501
Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the basic classes of
controlled substances:
Controlled substance
Schedule
Mephedrone
(4-Methyl-Nmethylcathinone) (1248).
1-Pentyl-3-(1-naphthoyl)indole)
(7118).
5-(1,1-Dimethylheptyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)
(7297).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Bromo-2,5dimethoxyamphetamine (7391).
3,4Methylenedioxymethamphetamine (7405).
Dimethyltryptamine (7435) ...........
Psilocyn (7438) .............................
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Oxycodone (9143) ........................
Thebaine (9333) ...........................
Fentanyl (9801) ............................
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances in dosage
form to distribute to researchers.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other activity
for these drug codes is authorized for
this registration.
The import of the above listed basic
classes of controlled substances would
be granted only for analytical testing
and clinical trials. This authorization
does not extend to the import of a
finished Food and Drug Administration
approved or non-approved dosage form
for commercial distribution in the
United States.
Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
substance. The DEA grants Meda
Pharmaceuticals, Inc., registration as an
importer of this controlled substance.
SUPPLEMENTARY INFORMATION: By notice
dated June 10, 2014, and published in
the Federal Register on June 17, 2014,
79 FR 34552, Meda Pharmaceuticals,
Inc., 705 Eldorado Street, Decatur,
Illinois 62523, applied to be registered
as an importer of a certain basic class of
controlled substance. No comments or
objections were submitted for this
notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of Meda Pharmaceuticals,
Inc., to import the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of nabilone (7379), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
FDA approved listed controlled
substance as a finished drug product in
dosage form for distribution to its
customers.
Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–23828 Filed 10–6–14; 8:45 am]
[FR Doc. 2014–23829 Filed 10–6–14; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Application: Chattem Chemicals, Inc.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
[Docket No. DEA–392]
ACTION:
Importer of Controlled Substances
Registration: Meda Pharmaceuticals,
Inc.
ACTION:
Notice of registration.
Meda Pharmaceuticals, Inc.,
applied to be registered as an importer
of a certain basic class of controlled
SUMMARY:
VerDate Sep<11>2014
17:15 Oct 06, 2014
Jkt 235001
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before November 6, 2014. Such
persons may also file a written request
DATES:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of importers,
of controlled substances (other than
final orders in connection with
suspension, denial, or revocation of
registration) has been redelegated to the
Deputy Assistant Administrator of the
DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.34(a), this is notice that on June
23, 2014, Chattem Chemicals, Inc., 3801
St. Elmo Avenue, Chattanooga,
Tennessee 37409, applied to be
registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
BILLING CODE 4410–09–P
Drug Enforcement Administration
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
November 6, 2014.
Methamphetamine (1105) ............
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
Schedule
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers. The company
plans to import an intermediate form of
Tapentadol (9780), and Thebaine (9333),
for the manufacture of other bulk
controlled substances and distribution
to its customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
E:\FR\FM\07OCN1.SGM
07OCN1
60502
Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
The company plans to import these
controlled substances for the
manufacture of reference standards.
[FR Doc. 2014–23827 Filed 10–6–14; 8:45 am]
BILLING CODE 4410–09–P
Dated: September 25, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
DEPARTMENT OF JUSTICE
[FR Doc. 2014–23830 Filed 10–6–14; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
DEPARTMENT OF LABOR
Importer of Controlled Substances
Registration: Alltech Associates, Inc.
ACTION:
Notice of registration.
[Docket No. OSHA–2011–0189]
Alltech Associates, Inc.,
applied to be registered as an importer
of certain basic classes of controlled
substances. The DEA grants Alltech
Associates, Inc., registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated May 28, 2014, and published in
the Federal Register on June 3, 2014, 79
FR 31986, Alltech Associates, Inc., 2051
Waukegan Road, Deerfield, Illinois
60015, applied to be registered as an
importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of Alltech Associates, Inc.,
to import the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the basic classes of
controlled substances listed:
SUMMARY:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Controlled substance
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Lysergic acid diethylamide (7315)
Heroin (9200) ...............................
Cocaine (9041) .............................
Codeine (9050) .............................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
VerDate Sep<11>2014
17:15 Oct 06, 2014
Occupational Safety and Health
Administration
I
I
I
II
II
II
II
II
II
Jkt 235001
Servicing Multi-Piece and Single Piece
Rim Wheels; Extension of the Office of
Management and Budget’s (OMB)
Approval of Information Collection
(Paperwork) Requirements
Occupational Safety and Health
Administration, Labor.
ACTION: Request for public comments.
AGENCY:
OSHA solicits public
comments concerning its proposal to
extend the Office of Management and
Budget’s (OMB) approval of the
information collection requirements
specified in the Standard on Servicing
Multi-Piece and Single Piece Rim
Wheels (29 CFR 1910.177). The
paperwork provisions of the Standard
includes a requirement that the
manufacturer or a Registered
Professional Engineer certify that
repaired restraining devices and barriers
meet the strength requirements
specified in the Standard and a
requirement that defective wheels and
wheel components be marked or tagged.
DATES: Comments must be submitted
(postmarked, sent, or received) by
December 8, 2014.
ADDRESSES: Electronically: You may
submit comments and attachments
electronically at https://
www.regulations.gov, which is the
Federal eRulemaking Portal. Follow the
instructions online for submitting
comments.
Facsimile: If your comments,
including attachments, are not longer
than 10 pages you may fax them to the
OSHA Docket Office at (202) 693–1648.
Mail, hand delivery, express mail,
messenger, or courier service: When
using this method, you must submit a
copy of your comments and attachments
to the OSHA Docket Office, Docket No.
OSHA–2011–0189, Occupational Safety
and Health Administration, U.S.
Department of Labor, Room N–2625,
200 Constitution Avenue NW.,
Washington, DC 20210. Deliveries
(hand, express mail, messenger, and
SUMMARY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
courier services) are accepted during the
Department of Labor’s and Docket
Office’s normal business hours, 8:15
a.m. to 4:45 p.m., e.t.
Instructions: All submissions must
include the Agency name and OSHA
docket number (OSHA–2011–0189) for
the Information Collection Request
(ICR). All comments, including any
personal information you provide, are
placed in the docket without change
and may be made available online at
https://www.regulations.gov. For further
information on submitting comments
see the ‘‘Public Participation’’ heading
in the section of this notice titled
‘‘SUPPLEMENTARY INFORMATION.’’
Docket: To read or download
comments or other materials in the
docket, go to https://www.regulations.gov
or the OSHA Docket Office at the
address above. All documents in the
docket (including this Federal Register
notice) are listed in the https://
www.regulations.gov index; however,
some information (e.g., copyrighted
material) is not publicly available to
read or download from the Web site. All
submissions, including copyrighted
material, are available for inspection
and copying at the OSHA Docket Office.
You may also contact Theda Kenney at
the address below to obtain a copy of
the ICR.
FOR FURTHER INFORMATION CONTACT:
Theda Kenney or Todd Owen,
Directorate of Standards and Guidance,
OSHA, U.S. Department of Labor, Room
N–3609, 200 Constitution Avenue NW.,
Washington, DC 20210; telephone (202)
693–2222.
SUPPLEMENTARY INFORMATION:
I. Background
The Department of Labor, as part of its
continuing effort to reduce paperwork
and respondent (i.e., employer) burden,
conducts a preclearance consultation
program to provide the public with an
opportunity to comment on proposed
and continuing information collection
requirements in accord with the
Paperwork Reduction Act of 1995
(PRA–95) (44 U.S.C. 3506(c)(2)(A)). This
program ensures that information is in
the desired format, reporting burden
(time and costs) is minimal, collection
instruments are clearly understood, and
OSHA’s estimate of the information
collection burden is accurate. The
Occupational Safety and Health Act of
1970 (the OSH Act) (29 U.S.C. 651 et
seq.) authorizes information collection
by employers as necessary or
appropriate for enforcement of the OSH
Act or for developing information
regarding the causes and prevention of
occupational injuries, illnesses, and
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60501-60502]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23827]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Chattem Chemicals,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before November 6, 2014. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before November 6, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
importers, of controlled substances (other than final orders in
connection with suspension, denial, or revocation of registration) has
been redelegated to the Deputy Assistant Administrator of the DEA
Office of Diversion Control (``Deputy Assistant Administrator'')
pursuant to section 7 of 28 CFR pt. 0, subpt. R, App.
In accordance with 21 CFR 1301.34(a), this is notice that on June
23, 2014, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Chattanooga,
Tennessee 37409, applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Methamphetamine (1105)..................... II
4-Anilino-N-phenethyl-4-piperidine (8333).. II
Phenylacetone (8501)....................... II
Thebaine (9333)............................ II
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers. The
company plans to import an intermediate form of Tapentadol (9780), and
Thebaine (9333), for the manufacture of other bulk controlled
substances and distribution to its customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007).
[[Page 60502]]
Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-23827 Filed 10-6-14; 8:45 am]
BILLING CODE 4410-09-P
